Laboratory Animal and Comparative Medicine 2024;44(1):105-114
doi:10.12300/j.issn.1674-5817.2023.146
Interpretation and Elaboration for the ARRIVE Guidelines 2.0—Animal Research: Reporting In Vivo Experiments (V)
Zhengwen MA 1 ; Xiaying LI 2 ; Xiaoyu LIU 3 ; Yao LI 1 ; Jian WANG 1 ; Jin LU 1 ; Guoyuan CHEN 4 ; Xiao LU 5 ; Yu BAI 6 ; Xuancheng LU 7 ; Yonggang LIU 8 ; Yufeng TAO 9 ; Wanyong PANG 10
Affiliations
Keywords
Animal experiment; ARRIVE 2.0 guidelines; ARRIVE Recommended set; Pain management; Animal care and monitoring
Country
China
Language
Chinese
Abstract
Improving the reproducibility of biomedical research results is a major challenge. Transparent and accurate reporting of the research process enables readers to evaluate the reliability of the research results and further explore the experiment by repeating it or building upon its findings. The ARRIVE 2.0 guidelines, released in 2019 by the UK National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs), provide a checklist that is applicable to any in vivo animal research report. These guidelines aim to improve the standardization of experimental design, implementation, and reporting, as well as enhance the reliability, repeatability, and clinical translation of animal experimental results. The use of the ARRIVE 2.0 guidelines not only enriches the details of animal experimental research reports, ensuring that information on animal experimental results is fully evaluated and utilized, but also enables readers to understand the content expressed by the author accurately and clearly, promoting the transparency and completeness of the fundamental research review process. At present, the ARRIVE 2.0 guidelines have been widely adopted by international biomedical journals. This article is based on the best practices following the ARRIVE 2.0 guidelines in international journals, and it interprets, explains, and elaborates in Chinese the fifth part of the comprehensive version of the ARRIVE 2.0 guidelines published in PLoS Biology in 2020 (the original text can be found at
备案号: 11010502037788, 京ICP备10218182号-8)